Jim Simons Care Dx, Inc. Transaction History

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Care Dx, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,155,698 shares of CDNA stock, worth $17.3 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

1,155,698

Previous 1,236,998 6.57%

Holding current value

$17.3 Million

Previous $22 Million 2.85%

% of portfolio

0.03%

Previous 0.04%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	SELL	$14.18 - $20.08 $1.15 Million - $1.63 Million	-81,300 Reduced 6.57%	1,155,698 $22.6 Million
Q1 2025 May 14, 2025	SELL	$17.64 - $25.07 $3.44 Million - $4.89 Million	-195,200 Reduced 13.63%	1,236,998 $22 Million
Q4 2024 Feb 13, 2025	BUY	$20.4 - $32.2 $4 Million - $6.32 Million	196,298 Added 15.88%	1,432,198 $30.7 Million
Q3 2024 Nov 13, 2024	SELL	$14.41 - $33.99 $3.99 Million - $9.41 Million	-276,800 Reduced 18.3%	1,235,900 $38.6 Million
Q2 2024 Aug 09, 2024	BUY	$7.56 - $16.15 $666,036 - $1.42 Million	88,100 Added 6.18%	1,512,700 $23.5 Million
Q1 2024 May 13, 2024	BUY	$7.96 - $12.37 $497,500 - $773,125	62,500 Added 4.59%	1,424,600 $15.1 Million
Q4 2023 Feb 13, 2024	BUY	$4.9 - $12.86 $1.55 Million - $4.06 Million	315,800 Added 30.18%	1,362,100 $16.3 Million
Q3 2023 Nov 14, 2023	SELL	$7.0 - $11.26 $964,600 - $1.55 Million	-137,800 Reduced 11.64%	1,046,300 $7.32 Million
Q2 2023 Aug 11, 2023	BUY	$7.61 - $9.46 $1.2 Million - $1.49 Million	157,200 Added 15.31%	1,184,100 $10.1 Million
Q1 2023 May 12, 2023	BUY	$8.83 - $17.61 $716,996 - $1.43 Million	81,200 Added 8.59%	1,026,900 $9.39 Million
Q4 2022 Feb 13, 2023	BUY	$10.88 - $20.05 $2.02 Million - $3.72 Million	185,300 Added 24.37%	945,700 $10.8 Million
Q3 2022 Nov 14, 2022	SELL	$16.06 - $26.39 $3.34 Million - $5.48 Million	-207,800 Reduced 21.46%	760,400 $12.9 Million
Q2 2022 Aug 12, 2022	BUY	$20.49 - $39.72 $13 Million - $25.3 Million	636,300 Added 191.71%	968,200 $20.8 Million
Q1 2022 May 13, 2022	BUY	$28.19 - $46.6 $6.8 Million - $11.2 Million	241,300 Added 266.34%	331,900 $12.3 Million
Q4 2021 Feb 11, 2022	SELL	$41.2 - $73.6 $8.58 Million - $15.3 Million	-208,300 Reduced 69.69%	90,600 $4.12 Million
Q3 2021 Nov 12, 2021	BUY	$59.15 - $91.99 $17.7 Million - $27.5 Million	298,900 New	298,900 $18.9 Million
Q2 2021 Aug 13, 2021	SELL	$63.02 - $95.11 $743,636 - $1.12 Million	-11,800 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$57.62 - $95.6 $679,916 - $1.13 Million	11,800 New	11,800 $803,000
Q4 2020 Feb 10, 2021	SELL	$41.43 - $77.09 $7.06 Million - $13.1 Million	-170,400 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$30.88 - $37.94 $5.26 Million - $6.46 Million	170,400 New	170,400 $6.47 Million
Q4 2019 Feb 13, 2020	SELL	$19.24 - $28.41 $4.75 Million - $7.02 Million	-247,000 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$20.03 - $40.08 $1.72 Million - $3.44 Million	-85,800 Reduced 25.78%	247,000 $5.59 Million
Q2 2019 Aug 12, 2019	BUY	$25.78 - $39.77 $1.69 Million - $2.61 Million	65,600 Added 24.55%	332,800 $12 Million
Q1 2019 May 14, 2019	BUY	$22.09 - $39.21 $2.73 Million - $4.85 Million	123,600 Added 86.07%	267,200 $8.42 Million
Q4 2018 Feb 13, 2019	BUY	$19.89 - $30.02 $2.86 Million - $4.31 Million	143,600 New	143,600 $3.61 Million

Others Institutions Holding CDNA

# of Institutions

211

Shares Held

55.8M

Call Options Held

85K

Put Options Held

33.1K

View Full List

About CareDx, Inc.

Ticker CDNA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 53,458,100
Market Cap $801M
Description
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for...

More about CDNA

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account